Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data

Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data

Wave Life Sciences shares fell to the mid-$15 range on December 18, 2025, following a volatile period sparked by positive Phase 1 data for its obesity drug candidate WVE-007 and a large equity offering. No new announcements drove the move; trading reflected continued volatility after the early December clinical data and financing. Analysts remain bullish, but dilution and early-stage risk weigh on the stock.
18 December 2025
Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals shares fell about 8% Thursday after a regulatory filing disclosed Chief Medical and Development Officer Dr. Dana Pizzuti will step down December 31. She will transition to a Strategic Regulatory and Development Advisor role in early 2026. The stock traded in the low-to-high $40s as investors reacted to the leadership change.
18 December 2025
Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Birkenstock shares fell 8% to $42.58 on Dec. 18 after the company posted record fiscal 2025 revenue of €2.1 billion and strong profit growth but issued cautious 2026 guidance citing tariff and currency pressures. The stock swung between $39.73 and $46.75 in heavy trading as investors reacted to margin concerns despite robust recent results.
Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

Edgewise Therapeutics shares fell 8.8% to $20.35 on Thursday, with no new company news released that day. The stock traded between $20.33 and $22.81 on volume of about 1.25 million shares. EWTX remains 38% below its 52-week high and 92% above its 52-week low. The company’s recent updates include a December stock option grant and a November board appointment.
ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries shares fell 10.6% Thursday to $43.13 after reporting adjusted Q4 EPS of $0.88, missing consensus, though revenue rose 5.4% to $2.295 billion, beating estimates. The company cited a $0.26 per-share hit from self-insurance adjustments and announced a $275 million acquisition. UBS downgraded the stock, citing margin and leverage concerns.
Inspire Medical Systems (INSP) Stock Plunges on Medicare Coding Reversal: Latest News, Analyst Forecasts, and What Investors Are Watching

Inspire Medical Systems (INSP) Stock Plunges on Medicare Coding Reversal: Latest News, Analyst Forecasts, and What Investors Are Watching

Inspire Medical Systems shares fell sharply on December 18, 2025, after two Medicare contractors, CGS and Noridian, pulled CPT code 64568 for hypoglossal nerve stimulation and redirected billing to CPT 64582. The move cast doubt on a key reimbursement upgrade that had driven recent stock gains, sending INSP down in the mid-to-high teens by early afternoon.
18 December 2025
Insmed Stock (NASDAQ: INSM) Slides on Brensocatib Sinus-Trial Failure; Analysts Reset Forecasts

Insmed Stock (NASDAQ: INSM) Slides on Brensocatib Sinus-Trial Failure; Analysts Reset Forecasts

Insmed shares fell 16% Thursday after the company said its Phase 2b trial of brensocatib in chronic rhinosinusitis without nasal polyps failed to meet endpoints, prompting it to end development for that indication. The drug’s performance matched or trailed placebo on symptom scores. Insmed reported no new safety issues. The stock traded near $166.75 after hitting a low of $158.06.
Upstart Stock News Today: UPST Jumps on Tech CU Partnership as Wall Street Weighs 2026 Outlook (Dec. 18, 2025)

Upstart Stock News Today: UPST Jumps on Tech CU Partnership as Wall Street Weighs 2026 Outlook (Dec. 18, 2025)

Upstart Holdings, Inc. (NASDAQ: UPST) is back in the spotlight on December 18, 2025 (18.12.2025), with the AI-lending stock pushing higher as traders react to fresh partner momentum in credit unions—and try to square that optimism with a still-volatile macro and a sharply divided analyst community. Shares were trading around the high-$40s on Thursday, up roughly 8% on the session at the time of this writing. Investing.com That move follows a choppy stretch for UPST, where single-day swings have become a feature, not a bug. Today’s catalyst is fairly clear: a new credit union partnership that reinforces Upstart’s strategy of
18 December 2025
ICE Barcelona 2026: Malta’s iGaming Push, Property Appeal and the EU’s Ukraine Funding Crunch

ICE Barcelona 2026: Malta’s iGaming Push, Property Appeal and the EU’s Ukraine Funding Crunch

Valletta / Brussels / Barcelona — December 18, 2025.Across Europe today, three storylines converged around the same theme: predictability—who can offer it, who needs it, and how much it costs. In Brussels, EU leaders entered what diplomats described as a make-or-break summit over a proposed €90 billion “reparations loan” for Ukraine, backed by profits from frozen Russian central bank assets—a plan that has exposed deep legal and financial anxieties inside the bloc. Reuters+2The Guardian+2 In the Mediterranean, Malta is leaning hard into the opposite narrative: a small jurisdiction selling stability at scale. On the same day, GamingMalta detailed how it
18 December 2025
BETA Technologies Stock (NYSE: BETA) Surges as BofA Raises Price Target and U.S. DOT Unveils Advanced Air Mobility Roadmap

BETA Technologies Stock (NYSE: BETA) Surges as BofA Raises Price Target and U.S. DOT Unveils Advanced Air Mobility Roadmap

BETA Technologies, Inc. stock (NYSE: BETA) became one of the more talked-about “future of flight” trades on December 18, 2025, as a classic one-two catalyst landed on the tape: a fresh analyst price-target increase from Bank of America and a major federal policy signal for the advanced air mobility (AAM) sector. By the latest reported trade late Thursday, BETA shares were at $29.88, up 6.83%, after touching an intraday high of $30.49. That price action is happening in a stock that only recently entered the public markets—BETA raised about $1.01 billion in its IPO at $34 per share, debuting on
18 December 2025
Karman Holdings (KRMN) Stock: News, Forecasts, and Analyst Outlook for December 18, 2025

Karman Holdings (KRMN) Stock: News, Forecasts, and Analyst Outlook for December 18, 2025

Karman Holdings Inc. (best known as Karman Space & Defense) is back on investors’ radar on Thursday, December 18, 2025, as fresh institutional ownership data and new valuation commentary collide with an already-heated 2025 run in aerospace and defense equities. One important housekeeping note up front: Karman Holdings Inc. trades on the NYSE under ticker KRMN—not ONDS. Reuters+1ONDS is the ticker for Ondas Holdings Inc., a separate defense-and-autonomy company that also made news today. Ondas Holdings Inc. With that clarified, here’s what’s new (and what matters) for Karman (KRMN) stock as of 12/18/2025, pulling together the day’s news, forecasts, and
18 December 2025
Applied Digital Corporation (APLD) Stock Jumps on New Macquarie Loan Facility: Today’s News, Analyst Forecasts, and What to Watch Next

Applied Digital Corporation (APLD) Stock Jumps on New Macquarie Loan Facility: Today’s News, Analyst Forecasts, and What to Watch Next

Applied Digital Corporation stock (NASDAQ: APLD) is snapping back on December 18, 2025, after a choppy week for “AI infrastructure” names. Shares were trading around $23.63 in midday U.S. trading, up roughly $1.63 (about 7.4%) from the prior close, with heavy volume as investors reacted to fresh financing news. MarketScreener That bounce matters because it arrives in the middle of a broader market argument: is the AI data-center boom still a gold rush—or are lenders and investors starting to ask harder questions about who pays for all this concrete, copper, power gear, and GPUs? Recent headlines around data-center financing (including
18 December 2025
Almonty Industries Stock (ALM, AII) on 18 December 2025: Sangdong Mine Hits “First Ore” Milestone, Funding Overhang Clears, and Analysts Re-Run the Models

Almonty Industries Stock (ALM, AII) on 18 December 2025: Sangdong Mine Hits “First Ore” Milestone, Funding Overhang Clears, and Analysts Re-Run the Models

Almonty Industries Inc. stock is back in the market’s spotlight on Thursday, December 18, 2025, as investors digest a rare combo of real-world progress underground and capital-markets cleanup above ground. The company says it has delivered the first truckload of ore to the run‑of‑mine (ROM) pad at its flagship Sangdong Tungsten Mine in South Korea—an operational handoff from “build mode” into “mine mode,” and a key step on the road to full-scale tungsten concentrate production. Business Wire In the U.S. listing, Almonty Industries (NASDAQ: ALM) traded around $8.52 late in the session, up roughly 8.7% versus the prior close, with
Core Natural Resources (CNR) Stock Jumps on Leer South Restart: 2026 Outlook, Analyst Targets, and What to Watch

Core Natural Resources (CNR) Stock Jumps on Leer South Restart: 2026 Outlook, Analyst Targets, and What to Watch

Core Natural Resources, Inc. (NYSE: CNR) shares surged Thursday after the coal producer announced a major operational milestone: the restart of longwall mining at its Leer South metallurgical mine in West Virginia. The move helped push CNR stock to about $90 in late trading, up roughly 8% on the day, with the session ranging from the low $80s to low $90s. This is Core Natural Resources (the coal company)—not to be confused with other “CNR” tickers in global markets. What happened on Dec. 18: Leer South longwall mining is back online In a release dated Dec. 18, 2025, Core said
18 December 2025
Rocket Lab Stock Jumps After Early U.S. Space Force Launch: RKLB News, Forecasts, and Fresh 2025 Valuation Debate (Dec. 18, 2025)

Rocket Lab Stock Jumps After Early U.S. Space Force Launch: RKLB News, Forecasts, and Fresh 2025 Valuation Debate (Dec. 18, 2025)

Rocket Lab Corporation (Nasdaq: RKLB) is back in the headlines on December 18, 2025, after the company pulled off a national-security launch ahead of schedule—an operational flex that helped lift the stock in Thursday trading and reignited the ongoing tug‑of‑war between “execution momentum” and “already-priced-in optimism.” Rocket Lab stock today: what’s driving RKLB on Dec. 18, 2025 Rocket Lab said it successfully launched the STP‑S30 mission for the U.S. Space Force’s Space Systems Command, completing the mission five months ahead of schedule. The launch—named “Don’t Be Such A Square”—lifted off just after midnight from Launch Complex 2 at the Mid‑Atlantic
Blue Origin Stands Down NS-37 Launch After Preflight Issue, Delaying Historic Flight for First Wheelchair User to Reach Space

Blue Origin Stands Down NS-37 Launch After Preflight Issue, Delaying Historic Flight for First Wheelchair User to Reach Space

Blue Origin called off its planned New Shepard NS-37 launch attempt on Thursday, Dec. 18, 2025, saying the team “observed an issue” during built-in preflight checks and is now assessing the next opportunity to launch. The suborbital mission is closely watched because it is slated to carry Michaela “Michi” Benthaus, an aerospace and mechatronics engineer who uses a wheelchair—positioning her to become the first wheelchair user to travel beyond the Kármán line, the widely recognized boundary of space. Blue Origin+1 The delayed flight is more than a space-tourism headline. It has become a high-profile test of how commercial spaceflight can
18 December 2025
Ondas Holdings (ONDS) Stock Today (Dec. 18, 2025): Shares Rally on Demining Pilot Results, New COO, and Fresh Analyst Targets

Ondas Holdings (ONDS) Stock Today (Dec. 18, 2025): Shares Rally on Demining Pilot Results, New COO, and Fresh Analyst Targets

Ondas Holdings Inc. (NASDAQ: ONDS) is back in the market’s spotlight on Thursday, December 18, 2025, with the stock trading around the $8 level and showing sharp intraday gains on unusually heavy volume—a reminder that ONDS is currently priced like a fast-moving “story stock,” not a sleepy industrial. As of the latest available real-time snapshot, ONDS was up roughly 8% on the session (to about $7.99) with tens of millions of shares traded. StockAnalysis What’s behind the move? Two company announcements dated Dec. 18—one tied to AI-driven humanitarian demining and one tied to executive leadership and scale—landed as investors are
18 December 2025
Banco BBVA Argentina (BBAR) Stock Surges on Dec. 18, 2025: Dividend Headlines, FX Overhaul Tailwinds, and Where Analysts See the Shares Next

Banco BBVA Argentina (BBAR) Stock Surges on Dec. 18, 2025: Dividend Headlines, FX Overhaul Tailwinds, and Where Analysts See the Shares Next

New York / Buenos Aires — December 18, 2025. Banco BBVA Argentina S.A. shares are back in the spotlight today after a sharp move higher in U.S. trading. The bank’s NYSE-listed American Depositary Shares (ADS) (ticker: BBAR) traded around $18.44, up roughly $1.48 on the session (about +8.7% versus the prior close), with trading ranging from roughly $16.57 to $18.50. That kind of single-day swing is not unusual for Argentine financial stocks, which often behave like a “macro instrument” first and a bank second. But today’s move is landing on top of a stack of genuinely fresh, stock-specific developments: a
18 December 2025
Heartflow (HTFL) Stock Surges on Insider Buying as Analysts See Upside: News, Forecasts, and Key Risks for December 18, 2025

Heartflow (HTFL) Stock Surges on Insider Buying as Analysts See Upside: News, Forecasts, and Key Risks for December 18, 2025

Heartflow, Inc. (NASDAQ: HTFL) is in the spotlight on December 18, 2025, after shares jumped sharply following a newly disclosed insider purchase—the kind of headline that can kick a newly public medtech name into high gear for a day (and sometimes longer). MarketBeat+2Investing.com+2 Below is a full, publication-ready breakdown of today’s news, the latest analyst forecasts, and the most important fundamentals shaping the Heartflow stock story right now. What happened to Heartflow stock on December 18, 2025? Heartflow stock rallied after news broke that Director Jeffrey C. Lightcap bought 40,000 shares in the open market. MarketBeat reported the stock was
18 December 2025
India’s SHANTI Bill Passes Parliament: Private Entry into Nuclear Power, Liability Overhaul, and Protests Explained

India’s SHANTI Bill Passes Parliament: Private Entry into Nuclear Power, Liability Overhaul, and Protests Explained

New Delhi witnessed a watershed moment in India’s clean-energy debate on December 18, 2025, as Parliament cleared the Sustainable Harnessing and Advancement of Nuclear Energy for Transforming India (SHANTI) Bill, 2025—legislation the government says will unlock investment and accelerate nuclear expansion, and critics say weakens accountability in one of the country’s most sensitive sectors. www.ndtv.com+2Reuters+2 The bill’s passage immediately triggered a political and social backlash: opposition parties raised alarms in the Rajya Sabha over safety, regulation, and liability, while power engineers, central trade unions and farmers’ groups announced nationwide protests from December 23, demanding the bill’s withdrawal. The Economic Times+2ETEnergyworld.com+2
18 December 2025
1 373 374 375 376 377 535

Stock Market Today

Suzhou TFC Optical (300394.SZ) stock: 3 signals to watch before China’s short, pre-holiday week

Suzhou TFC Optical (300394.SZ) stock: 3 signals to watch before China’s short, pre-holiday week

8 February 2026
Suzhou TFC Optical closed up 0.4% at 252.97 yuan Friday after heavy trading and sharp swings, ranking as the No. 2 most-traded Shenzhen stock via Stock Connect. Margin financing and securities lending fell, with net margin selling of 419 million yuan. Shanghai and Shenzhen markets will close Feb. 16–23 for the Spring Festival. The company expects 2025 net profit to rise 40–60% year-on-year.
GigaDevice Semiconductor stock price: What to watch for 603986 A-shares as memory crunch bites

GigaDevice Semiconductor stock price: What to watch for 603986 A-shares as memory crunch bites

8 February 2026
GigaDevice Semiconductor’s Class A shares closed at 276.17 yuan in Shanghai, down 0.6% Friday. The company faces a Feb. 11 shareholder vote on related-party transaction limits and an overseas auditor. Investors are watching for fallout from the global memory-chip shortage, which has pushed prices higher across the supply chain. GigaDevice’s shares have nearly doubled over the past year.
Astera Labs (ALAB) stock closes near $170 after 19% jump as earnings week looms

Astera Labs (ALAB) stock closes near $170 after 19% jump as earnings week looms

8 February 2026
Astera Labs shares jumped 18.9% to $169.85 Friday, trading as high as $170.01 on volume of 7.3 million. The move followed Amazon’s AI spending forecast and a nearly 6% gain in the PHLX Semiconductor Index. Astera reports fourth-quarter results Tuesday after market close, with revenue guidance at $245–$253 million.
Go toTop